Liao ZX[Author] - Search Results

Year	Number of Results
1981	1
1983	1
1994	1
1995	1
1997	2
2001	1
2002	1
2003	2
2004	1
2005	4
2006	6
2007	3
2008	2
2009	4
2010	10
2011	6
2012	13
2013	12
2014	13
2015	9
2016	6
2017	10
2018	10
2019	9
2020	7
2021	15
2022	12
2023	5
2024	5

1

Potential targeting of the tumor microenvironment to improve cancer virotherapy.

Liao ZX, Hsu SH, Tang SC, Kempson I, Yang PC, Tseng SJ. Liao ZX, et al. Pharmacol Ther. 2023 Oct;250:108521. doi: 10.1016/j.pharmthera.2023.108521. Epub 2023 Aug 30. Pharmacol Ther. 2023. PMID: 37657673 Review.

2

The chemistry and pharmacology of Ligularia przewalskii: A review.

Liu SJ, Tang ZS, Liao ZX, Cui CL, Liu HB, Liang YN, Zhang Y, Xu HB, Zhang DB, Zheng YT, Shi HX, Li SY. Liu SJ, et al. Among authors: liao zx. J Ethnopharmacol. 2018 Jun 12;219:32-49. doi: 10.1016/j.jep.2018.03.002. Epub 2018 Mar 8. J Ethnopharmacol. 2018. PMID: 29526703 Review.

3

Potential therapeutics using tumor-secreted lactate in nonsmall cell lung cancer.

Liao ZX, Kempson IM, Hsieh CC, Tseng SJ, Yang PC. Liao ZX, et al. Drug Discov Today. 2021 Nov;26(11):2508-2514. doi: 10.1016/j.drudis.2021.07.014. Epub 2021 Jul 27. Drug Discov Today. 2021. PMID: 34325010 Review.

4

Nanomodified strategies to overcome EGFR-tyrosine kinase inhibitors resistance in non-small cell lung cancer.

Liao ZX, Huang KY, Kempson IM, Li HJ, Tseng SJ, Yang PC. Liao ZX, et al. J Control Release. 2020 Aug 10;324:482-492. doi: 10.1016/j.jconrel.2020.05.043. Epub 2020 Jun 1. J Control Release. 2020. PMID: 32497570 Review.

5

Remote Control of Light-Triggered Virotherapy.

Tseng SJ, Huang KY, Kempson IM, Kao SH, Liu MC, Yang SC, Liao ZX, Yang PC. Tseng SJ, et al. Among authors: liao zx. ACS Nano. 2016 Nov 22;10(11):10339-10346. doi: 10.1021/acsnano.6b06051. Epub 2016 Nov 7. ACS Nano. 2016. PMID: 27934080

6

[Advances in color stability of resin cements and its influence on all-ceramics restorations].

Liao ZX, Zhou W, Zhang L, Qiu BY, Yu HH, Niu LN, Chen JH. Liao ZX, et al. Zhonghua Kou Qiang Yi Xue Za Zhi. 2021 Feb 9;56(2):216-220. doi: 10.3760/cma.j.cn112144-20200709-00407. Zhonghua Kou Qiang Yi Xue Za Zhi. 2021. PMID: 33557510 Review. Chinese.

7

Two new alkaloids from Tibetan medicine of Hypecoum leptocarpum.

Sun B, Assani I, Wang CG, Wang MX, Liu LF, Li Y, Yan G, Yang YR, Chen Z, Liao ZX. Sun B, et al. Among authors: liao zx. Nat Prod Res. 2022 Oct;36(20):5304-5310. doi: 10.1080/14786419.2021.1937154. Epub 2021 Jun 16. Nat Prod Res. 2022. PMID: 34130568

8

Switching Over of the Chemoselectivity: I₂-DMSO-Enabled α,α-Dichlorination of Functionalized Methyl Ketones.

Xiang JC, Wang JW, Yuan P, Ma JT, Wu AX, Liao ZX. Xiang JC, et al. Among authors: liao zx. J Org Chem. 2022 Nov 18;87(22):15101-15113. doi: 10.1021/acs.joc.2c01591. Epub 2022 Nov 8. J Org Chem. 2022. PMID: 36349364

9

pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications.

Sung HW, Sonaje K, Liao ZX, Hsu LW, Chuang EY. Sung HW, et al. Among authors: liao zx. Acc Chem Res. 2012 Apr 17;45(4):619-29. doi: 10.1021/ar200234q. Epub 2012 Jan 11. Acc Chem Res. 2012. PMID: 22236133 Review.

10

Leptin-elicited PBX3 confers letrozole resistance in breast cancer.

Pang ZY, Wei YT, Shang MY, Li S, Li Y, Jin QX, Liao ZX, Cui MK, Liu XY, Zhang Q. Pang ZY, et al. Among authors: liao zx. Endocr Relat Cancer. 2021 Feb 1:ERC-20-0328.R2. doi: 10.1530/ERC-20-0328. Online ahead of print. Endocr Relat Cancer. 2021. PMID: 33608482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

147 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Results by year